MYC and prostate cancer: Indeed, the increasing levels of MYC in castration-resistant prostate cancer [132] result in a global loss of H3K27me3 [133] (Fig. 3) and hence a global decrease in DNA methylation which is a characteristic feature of late- or end-stage metastatic prostate cancer [134].